MDS and MPN Diagnosis and Treatment Center
MDS和MPN诊疗中心 · Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin
Established in March 2001, this center focuses on the diagnosis, treatment, and research of myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), and acute myeloid leukemia. The team has developed diagnostic classification, prognosis assessment, and treatment selection strategies tailored to local conditions, which are widely used across the country. The center maintains 54 open beds and is staffed by eight physicians, including three chief physicians and two associate chief physicians. The nursing team consists of 24 members, with 13 holding supervisor-level titles or higher. Dr. Xiao Zhijian serves as the center director.
Conditions and treatments
- Diagnosis and treatment of myelodysplastic syndromes (MDS)
- Management of myeloproliferative neoplasms (MPN)
- Care for acute myeloid leukemia
- Prognosis assessment for MDS and MPN
- Treatment strategy selection for blood disorders
Key facts
- The center was established in March 2001.
- There are 54 open beds and 8 physicians, including 3 chief physicians.
- The nursing staff includes 24 members, with 13 holding supervisor-level titles or higher.
Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.
| Doctors listed | 5 |
|---|---|
| Chief physicians | — |
We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.
Need a specialist's opinion?
Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.
Contact us